Biosimilar Monoclonal Antibody Market Set to Triple, Reaching $40.77 Billion by 2032 as Patent Cliffs and Cost Pressures Drive Global Adoption
Kings Research has released its comprehensive analysis of the global biosimilar monoclonal antibody market, revealing that the sector is poised for extraordinary expansion over the coming seven years. Valued at USD 12.44 billion in 2025, the market is forecast to reach USD 40.77 billion by 2032, representing a compound annual growth rate (CAGR) of 18.48% — one of the highest...
0 Commentaires 0 Parts 119 Vue 0 Aperçu
Commandité
Myliveroom — Live Events & Online Communities https://myliveroom.com